Literature DB >> 19849692

Haemostatic role and histopathological effects of a new haemostatic agent in a rat bladder haemorrhage model: an experimental trial.

Ozcan Kilic1, Murat Gonen, Kadir Acar, Talat Yurdakul, Mustafa Cihat Avunduk, Haci Hasan Esen, Mehmet Oz.   

Abstract

OBJECTIVE: To investigate the haemostatic efficacy and histopathological effects of a new haemostatic agent, Ankaferd BloodStopper (ABS; Ankaferd Drug Cosmetic Co., Istanbul, Turkey) in a rat bladder haemorrhage model. ABS is a unique combination of five plant extracts that has been used in Turkish traditional medicine as a haemostatic agent for external traumatic bleeds.
MATERIALS AND METHODS: In all, 20 male Sprague-Dawley rats were divided into two equal groups. In both groups, the mucosa was damaged on the posterior wall (PW) of the bladder. The liquid form of ABS was applied to the bleeding area of one group (group 1) and 0.9% NaCl to the bleeding area of the other group (group 2, controls). The solutions were applied drop by drop with a 2 mL injector until the bleeding stopped and the bleeding times recorded. For histopathological examination, two tissue samples were taken from all rats in each group; one from the damaged mucosa in the PW and one from undamaged mucosa in the lateral wall (LW). Two sections were prepared from all samples. One section was stained with haematoxylin and eosin (H&E), and the rest was used for immunohistochemical staining for fibronectin.
RESULTS: The mean bleeding times were 65 s and 147 s for groups 1 and 2, respectively (P < 0.001). In the pathological specimens stained with H&amp;E, fibrosis and other studied pathological features were similar in the LW samples in groups 1 and 2. Similarly, there were no differences between the PW samples of groups 1 and 2. In the pathological specimens stained for fibronectin, the number of attenuated cells was similar in the LWs of group 1 and 2 (P = 0.21) as well as in the PWs of each group (P = 0.066).
CONCLUSIONS: ABS decreased bleeding time and did not increase fibrotic reactions in rat bladder tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19849692     DOI: 10.1111/j.1464-410X.2009.08985.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

1.  Unpredicted effects of Ankaferd® on cartilage tissue.

Authors:  Cenk Evren; Mehmet Birol Uğur; Burhan Yıldırım; Sibel Bektaş; Volkan Bilge Yiğit; Fikret Çınar
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Massive haematuria successfully managed by intravesical Ankaferd in a haemodialysis patient complicated with disseminated intravascular coagulation.

Authors:  Yalcin Solak; Abduzhappar Gaipov; Orhan Ozbek; Mustafa Aziz Hassan; Mehdi Yeksan
Journal:  BMJ Case Rep       Date:  2012-12-23

3.  Anti-inflammatory efficiency of Ankaferd blood stopper in experimental distal colitis model.

Authors:  Erdem Koçak; Erdem Akbal; Adnan Taş; Seyfettin Köklü; Gökhan Karaca; Murat Can; Bahadir Kösem; Hüseyin Üstün
Journal:  Saudi J Gastroenterol       Date:  2013 May-Jun       Impact factor: 2.485

4.  Effect of ankaferd blood stopper in experimental peritoneal adhesion model.

Authors:  Gokhan Karaca; Oktay Aydin; Faruk Pehlivanli; Ahmet Kocael; Recep Pekcici; Esat Duymus; Sukran Akgedik; Osman Guler
Journal:  Ann Surg Treat Res       Date:  2016-03-30       Impact factor: 1.859

Review 5.  Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).

Authors:  Rafiye Ciftciler; Ali Erdinc Ciftciler; Umit Yavuz Malkan; Ibrahim C Haznedaroglu
Journal:  SAGE Open Med       Date:  2020-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.